Biopsy-free AI-aided precision MRI assessment in prediction of prostate cancer biochemical recurrence.

AI-aided iBCR-Net using high-throughput MRI can predict PCa BCR accurately and thus may provide an alternative to the conventional method for PCa risk stratification.